← 返回

利用 IVIM DWI 生境分析成像口腔鳞状细胞癌肿瘤微环境异质性

英文原题:Imaging tumor microenvironment heterogeneity in oral squamous cell carcinoma using IVIM DWI habitat analysis.

查看英文原题

Imaging tumor microenvironment heterogeneity in oral squamous cell carcinoma using IVIM DWI habitat analysis.

PubMed 2026/09/09(内容时间) Eur Radiol Exp Q1 · IF 4.7(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

研究概要

基于 IVIM-DWI 的 habitat 成像为表征 OSCC 的扩散-灌注异质性提供了一种无创方法,并可能补充组织病理学评估以用于术前风险分层。问题:基于 IVIM-DWI 的 habitat 成像能否无创地表征 OSCC 的肿瘤微环境异质性,并识别与间质组成、免疫浸润和淋巴结转移相关的影像特征?

研究思路结论见上方概要

口腔鳞状细胞癌(OSCC)的肿瘤微环境(TME)在空间上具有异质性,并对预后产生关键影响。传统磁共振成像(MRI)扩散加权成像(DWI)指标平均了异质性,掩盖了相关的生物学瘤内模式。Habitat成像能够对扩散-灌注异质性进行体素级表征。

84例经病理确诊的OSCC患者被前瞻性纳入,并接受了术前多b值体素内不相干运动(IVIM)-DWI检查。基于扩散相关(D t)和灌注相关(f)参数,应用了体素级栖息地成像框架。使用人群水平的D t和f阈值定义了四个栖息地,对应扩散和灌注特征的不同组合,以确保患者间亚区定义的标准化。在组织病理学切片上评估了肿瘤-间质比(TSR)、TIL(肿瘤浸润淋巴细胞)(TILs)和颈部淋巴结转移(CLNM)。量化了栖息地指标,包括亚区百分比、体积以及平均D t和f值,并将其与肿瘤级病理表型进行相关性分析。评估了预测性能。

高TSR肿瘤在细胞稀少栖息区(亚区3和4)表现出更高的D t值,这独立预测了基质丰富表型。高TIL肿瘤在细胞为主、高灌注栖息区(亚区2)表现出较低的D t,并且细胞稀少、低灌注栖息区(亚区3)的比例降低,这与免疫富集微环境一致。CLNM阳性肿瘤表现出整体栖息区扩张,一个推测的基质为主栖息区体积增加与转移独立相关。基于栖息区的模型在预测TSR(受试者工作特征曲线下面积(AUC)= 0.791)和TILs(AUC = 0.782)方面优于全肿瘤表观扩散系数和D t。基于IVIM-DWI的栖息区成像识别出与TSR、TILs和CLNM相关的空间上不同的扩散-灌注栖息区,其区分能力优于传统全肿瘤扩散指标。相关性声明:基于IVIM-DWI的栖息区成像提供了TME特征的临床相关、无创生物标志物,改善了OSCC的术前风险分层,并支持更精确、个体化的治疗决策。

展开英文摘要原文

The tumor microenvironment (TME) of oral squamous cell carcinoma (OSCC) is spatially heterogeneous and critically influences prognosis. Conventional magnetic resonance imaging (MRI) diffusion-weighted imaging (DWI) metrics average heterogeneity and obscure relevant biological intratumoral patterns. Habitat imaging enables voxel-wise characterization of diffusion-perfusion heterogeneity.

Eighty-four patients with pathologically confirmed OSCC were prospectively enrolled and underwent preoperative multi-b-value intravoxel incoherent motion (IVIM)-DWI. A voxel-wise habitat imaging framework was applied based on diffusion-related (D t ) and perfusion-related (f) parameters. Four habitats were defined using population-level D t and f thresholds, corresponding to distinct combinations of diffusion and perfusion characteristics, to ensure standardized subregion definitions across patients. Tumor-stroma ratio (TSR), tumor-infiltrating lymphocytes (TILs), and cervical lymph node metastasis (CLNM) were assessed on histopathological sections. Habitat metrics, including subregional percentage, volume, and mean D t and f values, were quantified and correlated with tumor-level pathological phenotypes. The predictive performance was evaluated.

High-TSR tumors exhibited higher D t value within hypocellular habitats (subregions 3 and 4), which independently predicted a stroma-rich phenotype. High-TIL tumors demonstrated lower D t in a cellular-dominant, high-perfusion habitat (subregion 2) and a reduced percentage of hypocellular, low-perfusion habitat (subregion 3), consistent with immune-enriched microenvironments. CLNM-positive tumors showed overall habitat expansion, with increased volume of a putative stroma-dominant habitat independently associated with metastasis. Habitat-based models outperformed whole-tumor apparent diffusion coefficient and D t for predicting TSR (area under the receiver operating characteristic curve (AUC) = 0.791) and TILs (AUC = 0.782).

IVIM-DWI-based habitat imaging provides a noninvasive approach for characterizing diffusion-perfusion heterogeneity in OSCC and may complement histopathological assessment for preoperative risk stratification. KEY POINTS: Question: Can IVIM-DWI-based habitat imaging noninvasively characterize tumor microenvironment heterogeneity and identify imaging features associated with stromal composition, immune infiltration, and nodal metastasis in OSCC?

IVIM-DWI-based habitat imaging identified spatially distinct diffusion-perfusion habitats associated with TSR, TILs, and CLNM, with improved discrimination over conventional whole-tumor diffusion metrics. RELEVANCE STATEMENT: IVIM-DWI-based habitat imaging provides clinically relevant, noninvasive biomarkers of TME features, improving preoperative risk stratification and supporting more precise, individualized therapeutic decisionmaking in OSCC.

论文信息

作者
Li S、Zheng X、Huang Y、Ren J、Wu Y
第一作者单位
Department of Radiology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.China
通讯作者单位
Department of Radiology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. wuyw0103@hotmail.com.China
期刊
European radiology experimental2026 Sep 9
原文标识
PubMed 42714769 · DOI 10.1186/s41747-026-00794-z